Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
J Vasc Surg. 2010 Apr;51(4):801-9, 809.e1. doi: 10.1016/j.jvs.2009.10.115.
Highly variable utilization rates for a diverse group of surgical procedures are commonly ascribed to physician practice patterns rather than clinical considerations. A previous investigation by our group showed that variations in the rates of carotid endarterectomy (CEA) actually reflected regional risk factors for atherosclerosis, not physician density or other socio-economic drivers. In this study, we examine the use of endovascular abdominal aortic aneurysm repair (EVAR) over six years to test our hypothesis that the utilization of innovative vascular procedures by vascular surgeons more closely reflects disease prevalence and consistent clinical judgment than non-medical factors.
The Nationwide Inpatient Samples and State Inpatient Databases (2001-2006) were accessed to document the number and type of aneurysm repairs (EVAR versus open). Multiple metrics pertaining to clinical risk factors, socioeconomic status, access to care, provider distribution, and local healthcare capacity were quantitated for each state. We performed bivariate analysis, Pearson (PC) or Spearman (SC) correlations, and multiple regression modeling.
The total number of aneurysms repaired has not changed significantly (from 45,828 in 2001 to 45,111 in 2006). Over the same interval, the number of open AAA repair nationwide decreased by 48% while the number of AAA repaired endovascularly increased by 105%. In 2005, the utilization rate of EVAR among 29 states ranged widely from 39.3% to 69.9%. Use of EVAR was highest in states with higher incidences of aneurysms (PC = 0.43, P < .05), greater number of deaths from heart disease (PC = 0.42, P < .05), greater number of diabetes discharges (PC = 0.48, P < .005), higher number of carotid stenosis discharges (PC = 0.40, P < .05), and higher number of chronic obstructive pulmonary disorder (COPD) discharges (SC = 0.43, P < .05). Regional malpractice pressure, specifically the number of paid claims and mean malpractice premium, both exhibited positive correlations with the EVAR rate. The number of physicians, vascular surgeons, hospital beds, teaching hospitals, or trauma centers did not predict high utilization of EVAR nor did the other socio-economic indices tested.
While there was substantial regional variation in the use of EVAR, utilization of the less morbid procedure was well correlated with higher risk populations (number of diabetic patients and deaths secondary to heart disease). Contrary to other studies of regional discrepancies in the utilization of some surgical procedures, it appears that the utilization of EVAR was not associated with physician distribution, socioeconomics, or other non-medical factors.
对于一组不同的外科手术,其利用率差异很大,通常归因于医生的实践模式而不是临床考虑因素。我们小组之前的一项研究表明,颈动脉内膜切除术(CEA)的利用率差异实际上反映了动脉粥样硬化的区域风险因素,而不是医生密度或其他社会经济驱动因素。在这项研究中,我们检查了六年来血管外科医生使用血管内腹主动脉瘤修复术(EVAR)的情况,以检验我们的假设,即血管外科医生使用创新的血管手术更能反映疾病的流行程度和一致的临床判断,而不是非医疗因素。
访问全国住院患者样本和州住院患者数据库(2001-2006 年),记录动脉瘤修复术(EVAR 与开放)的数量和类型。为每个州量化了与临床危险因素、社会经济地位、获得护理的机会、提供者分布和当地医疗保健能力相关的多个指标。我们进行了双变量分析、皮尔逊(PC)或斯皮尔曼(SC)相关性分析和多元回归建模。
修复的动脉瘤总数没有明显变化(从 2001 年的 45828 例增加到 2006 年的 45111 例)。在同一时期,全国范围内的开放式 AAA 修复数量减少了 48%,而血管内修复的 AAA 数量增加了 105%。2005 年,29 个州的 EVAR 利用率范围很广,从 39.3%到 69.9%。EVAR 的使用率在动脉瘤发病率较高的州(PC = 0.43,P <.05)、心脏病死亡率较高的州(PC = 0.42,P <.05)、糖尿病出院人数较多的州(PC = 0.48,P <.005)、颈动脉狭窄出院人数较多的州(PC = 0.40,P <.05)和慢性阻塞性肺疾病(COPD)出院人数较多的州(SC = 0.43,P <.05)较高。区域医疗事故压力,特别是已支付的索赔数量和平均医疗事故保费,都与 EVAR 比率呈正相关。医生、血管外科医生、病床、教学医院或创伤中心的数量并不能预测 EVAR 的高利用率,也不能预测其他社会经济指标的利用率。
尽管 EVAR 的使用存在显著的区域差异,但这种风险较低的手术的使用与高风险人群(糖尿病患者和心脏病死亡人数)密切相关。与其他一些外科手术利用区域差异的研究相反,EVAR 的利用似乎与医生分布、社会经济状况或其他非医疗因素无关。